Amgen and Kyowa Kirin to jointly develop and commercialize KHK4083, a phase 3-ready, potential first-in-class treatment for atopic dermatitis

1 June 2021

Kyowa Kirin and Winhealth Pharma Group establish strategic cooperation on NESP® (darbepoetin α Injection)

28 December 2020

Kyowa Kirin Asia Pacific Pte Ltd clinches two accolades at SBR Management Excellence Awards 2020

03 December 2020

Kyowa Kirin Asia Pacific and Helsinn sign exclusive license and distribution agreement to strengthen their presence in Asia Pacific’s rare disease therapy area

01 December 2020